Double‐blind comparison of an oral <i>Escherichia coli</i> preparation and mesalazine in maintaining remission of ulcerative colitis

Kruis, Wolfgang; SCHÜTZ, E.; Frič, P; Fixa, B; Judmaier, G; Stolte, M.

doi:10.1046/j.1365-2036.1997.00225.x

Public

Double‐blind comparison of an oral Escherichia coli preparation and mesalazine in maintaining remission of ulcerative colitis

Published in Alimentary Pharmacology & Therapeutics • Oct 1, 1997

Authors:

Wolfgang Kruis

E. SCHÜTZ

P Frič

Abstract

BACKGROUND: Aminosalicylates are used as standard treatment for maintaining remission in ulcerative colitis. As yet, there is no other existing alternative with proven efficacy. In light of the hypothesis that the intestinal environment may contribute to the pathophysiology of ulcerative colitis, a ...

Subject

Mesalazine

Ulcerative colitis

Medicine

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!